These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 21221802)
1. Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role. Biet F; Gendt L; Anton E; Ballot E; Hugot JP; Johanet C Dig Dis Sci; 2011 Jun; 56(6):1794-800. PubMed ID: 21221802 [TBL] [Abstract][Full Text] [Related]
2. Specific antibodies against recombinant protein of insertion element 900 of Mycobacterium avium subspecies paratuberculosis in Japanese patients with Crohn's disease. Nakase H; Nishio A; Tamaki H; Matsuura M; Asada M; Chiba T; Okazaki K Inflamm Bowel Dis; 2006 Jan; 12(1):62-9. PubMed ID: 16374261 [TBL] [Abstract][Full Text] [Related]
3. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029 [TBL] [Abstract][Full Text] [Related]
4. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132 [TBL] [Abstract][Full Text] [Related]
5. Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 antigens in Crohn's disease patients. Shafran I; Piromalli C; Decker JW; Sandoval J; Naser SA; El-Zaatari FA Dig Dis Sci; 2002 Sep; 47(9):2079-81. PubMed ID: 12353858 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic anti-GP2 and anti-Saccharomyces cerevisiae antibodies in ruminants with paratuberculosis: A better understanding of the immunopathogenesis of Crohn's disease. Liaskos C; Gkoutzourelas A; Spyrou V; Koutsoumpas A; Athanasiou LV; Amiridis GS; Billinis C; Bogdanos DP Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):778-785. PubMed ID: 32035824 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Saibeni S; Folli C; de Franchis R; Borsi G; Vecchi M Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881 [TBL] [Abstract][Full Text] [Related]
9. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
10. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease. Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572 [TBL] [Abstract][Full Text] [Related]
11. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Bartůnková J; Kolárová I; Sedivá A; Hölzelová E Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458 [TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease. Russell RK; Ip B; Aldhous MC; MacDougall M; Drummond HE; Arnott ID; Gillett PM; McGrogan P; Weaver LT; Bisset WM; Mahdi G; Wilson DC; Satsangi J J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):161-7. PubMed ID: 19179877 [TBL] [Abstract][Full Text] [Related]
14. Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype. Takaishi H; Kanai T; Nakazawa A; Sugata F; Nikai A; Yoshizawa S; Hamamoto Y; Funakoshi S; Yajima T; Iwao Y; Takemura M; Ozaki S; Hibi T J Gastroenterol; 2012 Sep; 47(9):969-77. PubMed ID: 22644337 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease. Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949 [TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471 [TBL] [Abstract][Full Text] [Related]
17. Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's Disease. Degenhardt F; Dirmeier A; Lopez R; Lang S; Kunst C; Roggenbuck D; Reinhold D; Szymczak S; Rogler G; Klebl F; Franke A; Rieder F Inflamm Bowel Dis; 2016 Nov; 22(11):2648-2657. PubMed ID: 27753692 [TBL] [Abstract][Full Text] [Related]
18. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease. Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]